Allergan Spurns Ackman and Valeant's $46B Takeover Bid - Presented by: The Aol. On Network

Allergan formally rejected the $46 billion unsolicited takeover bid made by Valeant Pharmaceuticals, saying the proposal substantially undervalues the Botox maker. Dana Mattioli joins MoneyBeat.



Related Videos

Most Popular Videos

Latest Videos


Most Active by Volume

Company Last Sale Change Net / %
BAC $ 16.74 0.05 ▼ 0.30%
AVNR $ 12.49 5.75 ▲ 85.31%
YHOO $ 42.55 0.33 ▼ 0.77%
AAPL $ 101.63 0.03 ▼ 0.03%
FB $ 74.58 2.90 ▼ 3.74%
NOK $ 8.56 0.19 ▲ 2.27%
TWTR $ 49.38 2.73 ▼ 5.24%
MSFT $ 46.24 0.46 ▼ 0.97%

As of 9/15/2014, 04:15 PM
More Most Active